Keywords: gsk, sees, strong, efficacy, across, wide, age
GSK's sees strong efficacy across wide age group
Article | 12 June 2006
Europe's largest drugmaker, UK-based GlaxoSmithKline, says that data presented at the 2006 American Society of Clinical Oncology annual meeting in Atlanta, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
